Epidemiology Forecast of Plaque Psoriasis in 2030

Plaque psoriasis population to reach over 16.8 million by 2030 in the 7MM influenced by obesity, type 2 diabetes, and smoking.

The number of individuals diagnosed with plaque psoriasis in the US, Japan, France, Germany, Italy, Spain, and the UK is projected to increase from around 15,720,000 in 2020 to over 16,850,000 in 2030, at an annual growth rate (AGR) of 0.72% according to GlobalData, a leading data, and analytics company.

This increase in the prevalence of plaque psoriasis cases will subsequently increase the size of markets related to this disease throughout the forecast period.

Psoriasis About
Psoriasis is a recurrent and complex inflammatory skin disorder that can have tremendous physical and psychological impact on the sufferer

‘Any significant changes would not alter the size of the plaque psoriasis population at present.’

Plaque psoriasis is a chronic autoimmune condition that appears on the skin in patches of thick, red, scaly skin. This occurs because the skin cells receive a signal to produce new skin cells that build up and shed in scales and patches.

This build-up of the skin also causes pain and irritation. Scratching can lead to broken skin, bleeding, and infection.

The latest report about plaque psoriasis reveals that the prevalence of risk factors such as obesity, type 2 diabetes, and smoking may influence the estimated case numbers.

Diet for Psoriasis
Learn what causes psoriasis, the appropriate diet to follow and the importance of diet in the treatment of this medical condition.

Based on the estimates, the US will have the highest number of lifetime diagnosed prevalent cases of plaque psoriasis in 2030, with over 8.1 million cases, while Japan will have the lowest, with about 0.47 million.

The rising number of plaque psoriasis cases will be influenced by anticipated population changes over the next decade even though the proportion of people with the disease in the country will remain roughly the same.

Psoriasis Therapy can Reduce Coronary Inflammation
Psoriasis therapy can reduce coronary inflammation, thereby lowering the risk of cardiac events. Effect of therapy can be measured by a novel imaging biomarker called perivascular fat attenuation index (FAI).

Source-Medindia

Psoriasis Can Increase The Risk of Type 2 Diabetes
The type of inflammation seen in psoriasis is known to promote insulin resistance and diabetes.